/PRNewswire/ -- Surgical Lights Market Research Report by Technology, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19...
Nuvo Pharmaceuticals Inc. (OTCQX:MRVFF) Q3 2022 Earnings Conference Call November 14, 2022 11:00 AM ET Company Participants Jesse Ledger – President and Chief Executive Officer Mary-Jane...
MISSISSAUGA, Ontario — Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company…
Photo by Yiorgos Ntrahas on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc.Markets Group Inc. (OTCQX: OTCM), operator of the OTCQX®, OTCQB® and Pink® financial...
- Blexten Label Expanded to Include Ages as Young as 4 Years Old - - Includes Approval of 2.5mg/mL Oral Solution and 10mg orodispersible (Quick Melt) Tablet
/PRNewswire/ - August 12, 2021 – Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused...
/PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with...
/PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with...